Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Biovance Capital is a venture capital firm based in Portugal, with offices in Lisbon and Porto. The firm focuses on early-stage biopharma companies across Europe, particularly in Southern Europe. It operates with a team of professionals holding advanced degrees, including PhDs and MDs, and collaborates with research institutes, incubators, and accelerators.
Biovance Capital invests in seed and Series A rounds of early-stage biopharma companies. The firm targets sectors with potential for venture capital, mergers and acquisitions, or initial public offerings, ensuring a clear regulatory pathway and favorable reimbursement policies. Investments are primarily directed towards biotech companies with robust preclinical models and patented or patentable assets.
Yes, Biovance Capital often leads seed and Series A rounds in the biopharma sector.
The firm is open to follow-on investments, particularly in companies that demonstrate strong growth and potential for further development.
Specific details about the size of Biovance Capital's current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.